Skip to main content
Clinical Trials/NCT04681183
NCT04681183
Active, Not Recruiting
N/A

Pilot Study Evaluating Neuro-Imaging Correlates of Epigenetic Finding in Prediction of Chronic Postsurgical Pain

Children's Hospital Medical Center, Cincinnati1 site in 1 country13 target enrollmentDecember 14, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Post-surgical Pain
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
13
Locations
1
Primary Endpoint
Chronic post-surgical pain; Unabbreviated scale title "Chronic post-surgical pain scores"
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This pilot research study is being performed to learn more about pain and look at how pain changes brain chemistry and function. The research team would like to learn new information to better control chronic pain after surgery. This information collected in this research will be used to plan possible future visits. Participants in this study are being asked to participate because they are scheduled for an upcoming surgery. The research team would like to observe them before and after their surgery.

Detailed Description

This study is a pilot feasibility study in 30 healthy, preoperative children and young adults undergoing major surgery with high risk for chronic post-surgical pain (CPSP) to characterize the brain metabolite status of the Anterior cingulate cortices (ACC) and insula in pre-surgical adolescents and to understand the relationship between metabolite levels and CPSP. The investigators will also examine whether neurochemical tone in these regions is related to resting state functional connectivity with other brain regions. Correlations between differentially methylated CpG sites in genes enriching gamma aminobutyric acid (GABA) and Dopamine-DARPP-32 pathways and Glu/GABA levels in insula/ACC will be analyzed.

Registry
clinicaltrials.gov
Start Date
December 14, 2020
End Date
December 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female aged ≥ 8 yrs of age
  • English speaking;
  • Healthy (Defined as American Society of Anesthesiologists Physical Status 1 or 2)
  • Ability to provide assent/consent/parent permission.
  • Scheduled to undergo chest surgery (thoracotomy, thoracoscopy, Nuss procedure, pectus surgery, mastectomy), spine surgery, amputation, hernia repair or hip/knee replacement.

Exclusion Criteria

  • History of chronic pain conditions including migraines
  • Use of opioids chronically or for major surgery within the 6 months prior to enrollment
  • Severe obesity (BMI\>35 kg/m2)
  • Taking no more than two concomitant medications known to induce or inhibit CYP2D6 activity, including paroxetine, fluoxetine, cimetidine, and duloxetine or other medications used to treat attention deficit hyperactivity disorder (medications containing amphetamine or methylphenidate).
  • Use of hormonal contraceptives
  • Use of medications that may alter pain sensitivity (e.g. gabapentin,/pregabalin amitryptiline/other antidepressants, clonidine).
  • Active or history of renal/liver problems or congenital cardiac disease
  • Diagnosed developmental delay
  • Pregnant or lactating females
  • Any skin condition that prevents cuff application

Outcomes

Primary Outcomes

Chronic post-surgical pain; Unabbreviated scale title "Chronic post-surgical pain scores"

Time Frame: 2-6 months after surgery

Pain scores over prior 2 weeks reported 2-6 months after surgery; minimum value = 0, maximum value = 10; higher score means more severe pain

Secondary Outcomes

  • Resting state connectivity(1 - 8 weeks before surgery)
  • Correlation of DNAm of specified gene regions with outcomes(1-8 weeks before surgery or day of surgery)
  • Evoked pressure pain measures; Unabbreviated scale title "Evoked pressure pain measures"(1-2 weeks after surgery)

Study Sites (1)

Loading locations...

Similar Trials